177 results on '"Ronsisvalle, Simone"'
Search Results
2. Analytical methods and experimental quality in studies targeting carbonyls in electronic cigarette aerosols.
3. Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile
4. 1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity
5. Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists
6. Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment.
7. Aerosol Emissions from Heated Tobacco Products: A Review Focusing on Carbonyls, Analytical Methods, and Experimental Quality.
8. An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain
9. Evaluation of N-substituent structural variations in opioid receptor profile of LP1
10. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives
11. Evaluation of Crocin Content and In Vitro Antioxidant and Anti-Glycation Activity of Different Saffron Extracts.
12. DSC investigation of the effect of the new sigma ligand PPCC on DMPC lipid membrane
13. From NMDA receptor antagonists to discovery of selective σ2 receptor ligands
14. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting.
15. Different In Silico Approaches Using Heterocyclic Derivatives against the Binding between Different Lineages of SARS-CoV-2 and ACE2.
16. Chemical, Antioxidant and Biological Studies of Brassica incana subsp. raimondoi (Brassicaceae) Leaf Extract.
17. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand
18. The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment
19. Identification of a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells
20. The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation
21. Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain
22. Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells.
23. Evaluation of N-substitution in 6,7-benzomorphan compounds
24. Involvement of the Nociceptin/Orphanin FQ-NOP receptor system in the ventrolateral periaqueductal gray following mechanical allodynia in chronic pain
25. A new sigma ligand, (±)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect
26. Orobanche crenata Forssk. Extract Affects Human Breast Cancer Cell MCF-7 Survival and Viral Replication.
27. Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures
28. The multitarget opioid ligand LP1ʼs effects in persistent pain and in primary cell neuronal cultures
29. Effects of intraplantar Nocistatin and (±)-J 113397 injections on nociceptive behavior in a rat model of inflammation
30. Anti-amnesic properties of (±)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats
31. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia
32. In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia
33. A novel adamantane derivative attenuates retinal ischemia–reperfusion damage in the rat retina through σ1 receptors
34. Antibacterial and anti-biofilm activities of walnut pellicle extract (Juglans regia L.) against coagulase-negative staphylococci.
35. Erratum to: Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain
36. Identification of a Potent and Selective 5‑HT1A Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity.
37. Pharmacological properties and biochemical mechanisms of μ-opioid receptor ligands might be due to different binding poses: MD studies.
38. In vitro evaluation of biological activities of Orobanche crenata Forssk. leaves extract.
39. Quantum Chemical and Molecular Dynamics Studies of MUC1 Calix[4,8]arene Scaffold Based Anticancer Vaccine Candidates.
40. Molecular modeling and biological studies show that some μ-opioid receptor agonists might elicit analgesia acting as MMP-9 inhibitors.
41. Antioxidant and antimicrobial properties of Casteanea sativa Miller chestnut honey produced on Mount Etna (Sicily).
42. Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model
43. Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT1A receptor agonists for CNS disorders and neuropathic pain.
44. Structure-Activity Relationships within a Series of σ1 and σ2 Receptor Ligands: Identification of a σ2 Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma.
45. Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells
46. Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy.
47. SteeredMolecular Dynamics Simulations for StudyingProtein–Ligand Interaction in Cyclin-Dependent Kinase 5.
48. In Silico Modeling of the Immune System: Cellular and Molecular Scale Approaches.
49. Synthesis of 5-Alkynyl Isoxazolidinyl Nucleosides.
50. Benzisothiazolyliminothiazolidin-4-ones with Chondroprotective Properties: Searching for Potent and Selective Inhibitors of MMP-13.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.